These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24951841)

  • 1. Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat.
    Wakley AA; McBride AA; Vaughn LK; Craft RM
    Pharmacol Biochem Behav; 2014 Sep; 124():269-77. PubMed ID: 24951841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
    Craft RM; Leitl MD
    Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal hormone modulation of ∆
    Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
    Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
    Wakley AA; Wiley JL; Craft RM
    Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
    Wakley AA; Wiley JL; Craft RM
    Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats.
    Wakley AA; Craft RM
    Behav Brain Res; 2011 Jan; 216(1):200-6. PubMed ID: 20692296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.
    Tseng AH; Craft RM
    Psychopharmacology (Berl); 2004 Feb; 172(1):25-30. PubMed ID: 14991224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol-Δ
    Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
    Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
    Wakley AA; Craft RM
    Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of gonadal hormones on cannabinoid dependence.
    Marusich JA; Craft RM; Lefever TW; Wiley JL
    Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
    Craft RM; Britch SC; Buzitis NW; Clowers BH
    Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose- and time-dependent estradiol modulation of morphine antinociception in adult female rats.
    Craft RM; Ulibarri C; Leitl MD; Sumner JE
    Eur J Pain; 2008 May; 12(4):472-9. PubMed ID: 17869144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH; Harding JW; Craft RM
    Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
    Lichtman AH; Cook SA; Martin BR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):585-93. PubMed ID: 8632325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.
    Kinsey SG; Cole EC
    Eur J Pharmacol; 2013 Sep; 715(1-3):111-6. PubMed ID: 23769745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro transfer rate of 14C from acetate-1-14C into ovarian steroids in the rat ovary during the estrous cycle and effects of LH and FSH.
    Kimura F; Ishida S; Seto K; Kawakami M
    Endokrinologie; 1976 Jun; 67(2):172-83. PubMed ID: 986298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diminution of delta9-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development.
    Mason DJ; Lowe J; Welch SP
    Eur J Pharmacol; 1999 Sep; 381(2-3):105-11. PubMed ID: 10554877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.